18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial.

Míreanna comhchosúla

• Binary classification of ¹⁸F-flutemetamol PET using machine learning: comparison with visual reads and structural MRI.
  de réir: Vandenberghe, R, et al.
  Foilsithe / Cruthaithe: (2013)
• Phase 1 study of the Pittsburgh compound B derivative 18F-flutemetamol in healthy volunteers and patients with probable Alzheimer disease.
  de réir: Nelissen, N, et al.
  Foilsithe / Cruthaithe: (2009)
• Longitudinal changes in 18F-Flutemetamol amyloid load in cognitively intact APOE4 carriers versus noncarriers: Methodological considerations
  de réir: Emma S. Luckett, et al.
  Foilsithe / Cruthaithe: (2023-01-01)
• Software compatibility analysis for quantitative measures of [18F]flutemetamol amyloid PET burden in mild cognitive impairment
  de réir: Hugh G. Pemberton, et al.
  Foilsithe / Cruthaithe: (2023-05-01)
• Abeta amyloid deposition in the language system and how the brain responds.
  de réir: Nelissen, N, et al.
  Foilsithe / Cruthaithe: (2007)